• Wed, December 4, 2024

by: Thomas Matters

Billionaire Ken Griffin Just Increased Citadel's Position in This Unstoppable ETF by 277%

Ken Griffin's Citadel Advisors just increased its stake in a very successful S&P 500-themed ETF.

by: Thomas Matters

Top AI Stocks For 2024: Investment Tips From An Expert

by: Thomas Matters

Intel Axes CEO Pat Gelsinger: Is It Time to Buy the Struggling Chip Stock?

Gelsinger spent most of his career at Intel, rising to chief technology officer before leaving to run VMWare in 2012 and then returning as CEO in 2021. He was generally well respected by Wall Street and industry insiders, but on his watch, the stock underperformed the market as Intel lost ground in the AI race to Nvidia.

by: Thomas Matters

Traders Focus On Central Bank Action in India After Poor GDP Growth

Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look at:

by: Thomas Matters

Top oil and gas stocks to buy now in Australia

Analysts believe that these stocks could energise portfolios with some big returns. The post Top oil and gas stocks to buy now in Australia appeared first on The Motley Fool Australia.

by: Thomas Matters

Brokers Suggest Investing in MakeMyTrip (MMYT): Read This Before Placing a Bet

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price,

by: Thomas Matters

SIMON BROWN: Yes, buy top stocks for the bottom drawer

When I was learning about markets in the 1980s, was something that was often mentioned was the idea of bottom-drawer shares.

by: Thomas Matters

2 Dividend-Paying Stocks Suze Orman Says To Consider Investing In

When it comes to the markets, the results of the recent election have caused jubilation in some corners of the country and fear in others. In a post-election episode of her "Women &

by: Thomas Matters

10 Of The Best Investment Apps For Android Users (According To User Rating)

It's easier than ever to engage with the stock and bond markets via your Android phone, and these apps have made the experience enjoyable, to boot.

by: Thomas Matters

Understanding The Difference Between Value VS. Market Cap Weighted

When it comes to investing, two common methods of portfolio construction and index strategies are value-weighted and market-cap weighted approaches. Both of these strategies offer unique ways of measuring the importance of individual assets within a portfolio or index,

by: Thomas Matters

Why Janux Therapeutics Crushed the Market Today

by: Thomas Matters

Where Will Dogecoin Be in 1 Year?

Dogecoin ( DOGE -0.17%) is up more than 350% in 2024, and there's a real chance it could continue rocketing higher. Although it's tempting to buy Dogecoin right now, I'll outline one of the primary catalysts fueling its rise and make the case for why investors are best off leaving it alone.

by: Thomas Matters

Why Pure Storage Stock Is Skyrocketing Today

by: Thomas Matters

Why Couchbase Stock Is Crashing Today

by: Thomas Matters

Infineon: A Solid Play On AI, But Some Challenges Remain

Infineon Technologies, a former Siemens subsidiary, is a solid long-term investment with a moat and strong market position. Find out why IFNNY stock is a hold.

by: Thomas Matters

Should You Buy Nvidia Stock Hand Over Fist Before the End of 2024? Here's What History Suggests.

by: Thomas Matters

SBI MF makes entry into quant fund category; should you invest?

SBI Quant Fund, which opened for subscription on December 4, marks the entry of the fund house into the quant space.

by: Thomas Matters

Two Private Credit ETFs Launch in a Single Day in New Gold Rush

The first two exchange-traded funds to hold private credit loans began trading on the same day, with issuers racing to tap into one of the investing world's hottest trends.

by: Thomas Matters

From getting a foot in the door to investing in global giants

This idea of 'earning a dividend cheque while you slept' and having something to replace your income became quite appealing to me and a pretty big part of my investment strategy' - Craig Antonie, chief investment officer of AnBro Capital Investments.

by: Thomas Matters

Dow Jones Industrial Average stuck near record highs with little momentum

by: Thomas Matters

The a2 Milk Company: Maiden Dividend And Financial Prospects Are Key Considerations

A favorable development for The a2 Milk Company (ACOPF) is the company's initiation of a maiden dividend policy. See why I rate the stock a hold.

by: Thomas Matters

Earnings On The Rise: 25 Stocks With Largest Upward Revisions To Consensus Estimates

Expectations play a key role in determining if a stock's price rises or falls when actual earnings are reported. Investors quickly learn that the market is forward-looking. Security prices are established through expectations, and prices fluctuate as these expectations change or are proven incorrect.

by: Thomas Matters

If I'd put $5,000 into CBA shares just 1 year ago, here's what I'd have now

Let's see if it were a good idea to buy this banking giant's shares a year ago. The post If I'd put $5,000 into CBA shares just 1 year ago, here's what I'd have now appeared first on The Motley Fool Australia.

by: Thomas Matters

Why Capital One (COF) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

by: Thomas Matters

Why Investing For Dividends Should Be A No-Brainer

Dividends offer reliable income without the need to sell shares. Read why investors should consider investing in quality, dividend stocks for the long haul.

by: Thomas Matters

Rob Gronkowski's net worth changes after remembering he invested $69,000 in Apple 10 years ago

Former New England Patriots star tight end Rob Gronkowski recently remembered a $69k Apple investment from 2014 that is now worth over $600k with the company

by: Thomas Matters

Why Is Immatics N.V. (IMTX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?

We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds. In this article, we are going to take a look at where Immatics N.V. (NASDAQ:IMTX) stands against the other small-cap biotech stocks.
  • Thu, December 5, 2024

by: Motley Fool Australia

1 Australian energy stock to buy confidently and 1 to avoid for now

These two Australian energy stocks sit at opposite ends of the pole for investors to consider. Let's take a look.

by: The Daily Telegraph

In 1964, we recommended five shares - we'd buy these again today

Questor celebrates its 60th anniversary this week, offering a good opportunity to draw parallels between 1964 and today...

by: Seeking Alpha

The Cost Of Euphoria: Why Palantir's Rally Could Be A Mirage

Palantir's impressive quarterly results and growth rates are overshadowed by the unrealistic expectations for future FCF growth. Read why PLTR stock is a Sell.

by: The Motley Fool

Why Intuitive Machines Stock Just Crashed 14%

According to data from S&P Global Market Intelligence, Intuitive burned through more than $75 million in free cash flow last year, and cash burn has increased this year. Although Intuitive has won several lucrative contracts from NASA, Wall Street analysts don't expect it to turn free-cash-flow-positive and begin earning profits until 2026.

by: The Motley Fool

Why C3.ai Stock Soared 51% in November

C3.ai stock rose 7% on Nov. 5 and jumped another 5% on Nov. 6 in response to the U.S. election results.

by: Thomas Matters

Stellantis Is Headed for Disaster

Stellantis ( STLA 1.76%) seemed to be on the path to recovery after the worst of the pandemic, but now that the market has gotten back to a more normalized supply-and-demand environment, the company's sales have dropped. In this video, Travis Hoium shows why strategic difficulties are at the core of Stellantis' problems.

by: Thomas Matters

Got $5,000? These 3 Growth Stocks Are Bargain Buys Right Now.

Three stocks that I think could be good growth stocks if you have $5,000 to invest today are Pfizer ( PFE -1.29%), ExxonMobil ( XOM -2.88%), and Carnival Corp. ( CCL 2.57%). Here's why these can be ideal options for growth investors, particularly if you're looking for good value buys, as well.

by: Thomas Matters

The CRA is Watching TFSA Holders: Here Are Some Red Flags to Avoid

There are some bad red flags that many investors may be overlooking, but fear not! Here's how to side step them, and invest.

by: Thomas Matters

The UK tech stocks worth owning

by: Thomas Matters

Google's new gen AI video model Veo available on Vertex AI private preview

by: Thomas Matters

3 ASX 300 shares with ex-dividend dates before the end of 2024

Do you want the latest payment from these shares that are set to trade ex-dividend? The post 3 ASX 300 shares with ex-dividend dates before the end of 2024 appeared first on The Motley Fool Australia.

by: Thomas Matters

2 high-yield ASX dividend shares for Australian retirees

Analysts are tipping these shares as buys and expect big things from them. The post 2 high-yield ASX dividend shares for Australian retirees appeared first on The Motley Fool Australia.

by: Thomas Matters

5 things to watch on the ASX 200 on Thursday

A better session is expected for Aussie investors today. Here's what you need to know. The post 5 things to watch on the ASX 200 on Thursday appeared first on The Motley Fool Australia.

by: Thomas Matters

Dow Jones Futures: Bitcoin Hits $100,000; Nvidia Ready To Run?

The major indexes hit highs Wednesday and bitcoin topped $100,000 late following Fed chief Powell comments. Is Nvidia ready to run?

by: Thomas Matters

Here's Why Dave Inc. (DAVE) is a Great Momentum Stock to Buy

by: Thomas Matters

Tony Robbins: These 3 Investments Can Make You Rich

Investing is a key component of building wealth, but some investments will pay off much more than others. For You: How To Get a 10% Return on Investment (ROI): 10 Proven Ways Learn More:

by: Thomas Matters

CMC Invest launches a flexible Isa - here's how it compares to rivals as it becomes the latest platform to offer tax-free account

by: MSN

Here are the top 10 ASX 200 shares today

The ASX was back to fine form this Thursday... The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

by: Thomas Matters

News Highlights: Top Company News of the Day - Thursday at 1 AM ET

by: Thomas Matters

Best mid cap mutual funds to invest in December 2024

Mid cap mutual funds invest in mid cap stocks or in stocks of medium-sized companies. As per Sebi norms, mid cap schemes are mandated to invest in companies that are between 101 and 250 in the market capitalisation.

by: Thomas Matters

Top Australian financial stocks to buy now

Financias for financial freedom. The post Top Australian financial stocks to buy now appeared first on The Motley Fool Australia.

Why Is Immatics N.V. (IMTX) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?

We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds. In this article, we are going to take a look at where Immatics N.V. (NASDAQ:IMTX) stands against the other small-cap biotech stocks.
The article from MSN Money discusses why Immatics N.V. (IMTX) is considered one of the best small-cap biotech stocks with significant potential, according to hedge funds. Immatics is a clinical-stage biopharmaceutical company focused on the development of T-cell receptor (TCR) therapies for cancer. The company's innovative approach involves using its proprietary technology to identify and target cancer-specific antigens, which has attracted attention from investors. Hedge funds are particularly interested due to Immatics' promising pipeline, including its lead candidate IMA201, which has shown encouraging results in early clinical trials for treating solid tumors. Additionally, the company's strategic partnerships, like the one with Bristol Myers Squibb, and its robust financial backing, provide a strong foundation for growth. The article highlights that hedge funds see Immatics as undervalued with a high potential for returns, given its advanced technology, clinical progress, and the expanding market for personalized cancer treatments.

Read the Full MSN Article at:
https://www.msn.com/en-us/money/savingandinvesting/why-is-immatics-n-v-imtx-among-the-best-small-cap-biotech-stocks-with-massive-potential-according-to-hedge-funds/ar-AA1vh8Pa